{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:44:41Z","timestamp":1791265481227,"version":"4.1.0"},"reference-count":82,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2013,3,19]],"date-time":"2013-03-19T00:00:00Z","timestamp":1363651200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0059347","type":"journal-article","created":{"date-parts":[[2013,3,19]],"date-time":"2013-03-19T21:03:51Z","timestamp":1363727031000},"page":"e59347","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":21,"title":["Recombinant Yellow Fever Viruses Elicit CD8+ T Cell Responses and Protective Immunity against Trypanosoma cruzi"],"prefix":"10.1371","volume":"8","author":[{"given":"Raquel Tayar","family":"Nogueira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alanderson Rocha","family":"Nogueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirian Claudia Souza","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maur\u00edcio Martins","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia Cristina da Costa","family":"Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Galler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myrna Cristina","family":"Bonaldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,3,19]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.idc.2012.03.002","article-title":"American trypanosomiasis (Chagas disease)","volume":"26","author":"A Rassi","year":"2012","journal-title":"Infect Dis Clin North Am"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.actatropica.2009.11.003","article-title":"Chagas disease: a Latin American health problem becoming a world health problem","volume":"115","author":"GA Schmunis","year":"2010","journal-title":"Acta Trop"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Albajar-Vinas P, Jannin J (2011) The hidden Chagas disease burden in Europe. Euro Surveill 16.","DOI":"10.2807\/ese.16.38.19975-en"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.4161\/hv.7.11.17016","article-title":"Advances and challenges towards a vaccine against Chagas disease","volume":"7","author":"I Quijano-Hernandez","year":"2011","journal-title":"Hum Vaccin"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"e3771","DOI":"10.1136\/bmj.e3771","article-title":"Plan to stimulate research in developing countries is put on hold","volume":"344","author":"A Gulland","year":"2012","journal-title":"BMJ"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1590\/S0074-02762009000900037","article-title":"Swimming against the current: genetic vaccination against Trypanosoma cruzi infection in mice","volume":"104","author":"M Rodrigues","year":"2009","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.meegid.2009.02.009","article-title":"Vaccine development against Trypanosoma cruzi and Leishmania species in the post-genomic era","volume":"9","author":"E Dumonteil","year":"2009","journal-title":"Infect Genet Evol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1586\/erv.09.45","article-title":"Vaccination approaches against Trypanosoma cruzi infection","volume":"8","author":"SI Cazorla","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1017\/S1462399410001560","article-title":"The endless race between Trypanosoma cruzi and host immunity: lessons for and beyond Chagas disease","volume":"12","author":"C Junqueira","year":"2010","journal-title":"Expert Rev Mol Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"e916","DOI":"10.1371\/journal.pntd.0000916","article-title":"The potential economic value of a Trypanosoma cruzi (Chagas disease) vaccine in Latin America","volume":"4","author":"BY Lee","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.0105-2896.2004.00183.x","article-title":"Generation, specificity, and function of CD8+ T cells in Trypanosoma cruzi infection","volume":"201","author":"D Martin","year":"2004","journal-title":"Immunol Rev"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1590\/S0001-37652003000400005","article-title":"Importance of CD8 T cell-mediated immune response during intracellular parasitic infections and its implications for the development of effective vaccines","volume":"75","author":"M Rodrigues","year":"2003","journal-title":"An Acad Bras Cienc"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.4049\/jimmunol.174.3.1594","article-title":"Antigen-specific T cells maintain an effector memory phenotype during persistent Trypanosoma cruzi infection","volume":"174","author":"DL Martin","year":"2005","journal-title":"J Immunol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.1128\/IAI.73.8.4934-4940.2005","article-title":"Type 1 immunity provides both optimal mucosal and systemic protection against a mucosally invasive, intracellular pathogen","volume":"73","author":"D Hoft","year":"2005","journal-title":"Infect Immun"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"e22011","DOI":"10.1371\/journal.pone.0022011","article-title":"Subdominant\/cryptic CD8 T cell epitopes contribute to resistance against experimental infection with a human protozoan parasite","volume":"6","author":"MR Dominguez","year":"2011","journal-title":"PLoS One"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1086\/381682","article-title":"Frequency of interferon- gamma -producing T cells specific for Trypanosoma cruzi inversely correlates with disease severity in chronic human Chagas disease","volume":"189","author":"S Laucella","year":"2004","journal-title":"J Infect Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S0002-9440(10)64094-1","article-title":"Modulation of chemokine production and inflammatory responses in interferon-gamma- and tumor necrosis factor-R1-deficient mice during Trypanosoma cruzi infection","volume":"158","author":"JC Aliberti","year":"2001","journal-title":"Am J Pathol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1128\/IAI.63.12.4862-4867.1995","article-title":"Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages","volume":"63","author":"JS Silva","year":"1995","journal-title":"Infect Immun"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1128\/IAI.01459-08","article-title":"Perforin and gamma interferon expression are required for CD4+ and CD8+ T-cell-dependent protective immunity against a human parasite, Trypanosoma cruzi, elicited by heterologous plasmid DNA prime-recombinant adenovirus 5 boost vaccination","volume":"77","author":"B de Alencar","year":"2009","journal-title":"Infect Immun"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1590\/S0074-02762009000900030","article-title":"The effects of nitric oxide on the immune system during Trypanosoma cruzi infection","volume":"104","author":"FR Gutierrez","year":"2009","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1128\/IAI.74.4.2477-2481.2006","article-title":"Distinct kinetics of effector CD8+ cytotoxic T cells after infection with Trypanosoma cruzi in naive or vaccinated mice","volume":"74","author":"F Tzelepis","year":"2006","journal-title":"Infect Immun"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"P\u00e9rez Brandan C, Basombr\u00edo MA (2012) Genetically attenuated Trypanosoma cruzi parasites as a potential vaccination tool. Bioengineered 3.","DOI":"10.4161\/bbug.20680"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1086\/652872","article-title":"Redirection of the immune response to the functional catalytic domain of the cystein proteinase cruzipain improves protective immunity against Trypanosoma cruzi infection","volume":"202","author":"S Cazorla","year":"2010","journal-title":"J Infect Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1590\/S0074-02762010000500015","article-title":"Immune responses to gp82 provide protection against mucosal Trypanosoma cruzi infection","volume":"105","author":"CS Eickhoff","year":"2010","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"6017","DOI":"10.1128\/IAI.73.9.6017-6025.2005","article-title":"CD8+-T-cell-dependent control of Trypanosoma cruzi infection in a highly susceptible mouse strain after immunization with recombinant proteins based on amastigote surface protein 2","volume":"73","author":"A Ara\u00fajo","year":"2005","journal-title":"Infect Immun"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"6889","DOI":"10.4049\/jimmunol.179.10.6889","article-title":"Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic trypanosoma cruzi immunity involving CD8+ CTL and B cell-mediated cross-priming","volume":"179","author":"DF Hoft","year":"2007","journal-title":"J Immunol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"6154","DOI":"10.1016\/j.vaccine.2009.08.026","article-title":"Efficient protective immunity against Trypanosoma cruzi infection after nasal vaccination with recombinant Sendai virus vector expressing amastigote surface protein-2","volume":"27","author":"X Duan","year":"2009","journal-title":"Vaccine"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1089\/hum.2006.17.898","article-title":"Long-term protective immunity induced against Trypanosoma cruzi infection after vaccination with recombinant adenoviruses encoding amastigote surface protein-2 and trans-sialidase","volume":"17","author":"AV Machado","year":"2006","journal-title":"Hum Gene Ther"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"7356","DOI":"10.1128\/IAI.73.11.7356-7365.2005","article-title":"Immune responses against a single CD8+-T-cell epitope induced by virus vector vaccination can successfully control Trypanosoma cruzi infection","volume":"73","author":"Y Miyahira","year":"2005","journal-title":"Infect Immun"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.ijpara.2010.05.011","article-title":"Quantitative and qualitative features of heterologous virus-vector-induced antigen-specific CD8+ T cells against Trypanosoma cruzi infection","volume":"40","author":"E Takayama","year":"2010","journal-title":"Int J Parasitol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1128\/IAI.01190-10","article-title":"Heterologous plasmid DNA prime-recombinant human adenovirus 5 boost vaccination generates a stable pool of protective long-lived CD8(+) T effector memory cells specific for a human parasite, Trypanosoma cruzi","volume":"79","author":"PO Rigato","year":"2011","journal-title":"Infect Immun"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"7414","DOI":"10.1016\/j.vaccine.2010.08.104","article-title":"Effect of a combination DNA vaccine for the prevention and therapy of Trypanosoma cruzi infection in mice: role of CD4+ and CD8+ T cells","volume":"28","author":"AY Limon-Flores","year":"2010","journal-title":"Vaccine"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1574-695X.2007.00251.x","article-title":"Comparative evaluation of therapeutic DNA vaccines against Trypanosoma cruzi in mice","volume":"50","author":"G Sanchez-Burgos","year":"2007","journal-title":"FEMS Immunol Med Microbiol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.vaccine.2008.02.011","article-title":"Prime-boost immunization with cruzipain co-administered with MALP-2 triggers a protective immune response able to decrease parasite burden and tissue injury in an experimental Trypanosoma cruzi infection model","volume":"26","author":"S Cazorla","year":"2008","journal-title":"Vaccine"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"7046","DOI":"10.1016\/j.vaccine.2006.07.006","article-title":"The genetic immunization with paraflagellar rod protein-2 fused to the HSP70 confers protection against late Trypanosoma cruzi infection","volume":"24","author":"M Morell","year":"2006","journal-title":"Vaccine"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.molimm.2012.05.021","article-title":"Trypanosoma cruzi paraflagellar rod proteins 2 and 3 contain immunodominant CD8(+) T-cell epitopes that are recognized by cytotoxic T cells from Chagas disease patients","volume":"52","author":"A Egui","year":"2012","journal-title":"Mol Immunol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.4049\/jimmunol.151.5.2676","article-title":"Trypanosoma cruzi: immunity-induced in mice and rats by trypomastigote excretory-secretory antigens and identification of a peptide sequence containing a T cell epitope with protective activity","volume":"151","author":"A Taibi","year":"1993","journal-title":"J Immunol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"6558","DOI":"10.1128\/IAI.69.10.6558-6563.2001","article-title":"DNA immunization with Trypanosoma cruzi HSP70 fused to the KMP11 protein elicits a cytotoxic and humoral immune response against the antigen and leads to protection","volume":"69","author":"L Planelles","year":"2001","journal-title":"Infect Immun"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1089\/hum.2004.15.878","article-title":"Protective immunity against trypanosoma cruzi infection in a highly susceptible mouse strain after vaccination with genes encoding the amastigote surface protein-2 and trans-sialidase","volume":"15","author":"J Vasconcelos","year":"2004","journal-title":"Hum Gene Ther"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"5547","DOI":"10.1128\/IAI.70.10.5547-5555.2002","article-title":"Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection","volume":"70","author":"N Garg","year":"2002","journal-title":"Infect Immun"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"6018","DOI":"10.1016\/j.vaccine.2007.05.022","article-title":"Cross-priming of long lived protective CD8+ T cells against Trypanosoma cruzi infection: importance of a TLR9 agonist and CD4+ T cells","volume":"25","author":"B de Alencar","year":"2007","journal-title":"Vaccine"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1590\/S0074-02762009000900027","article-title":"Cellular and genetic mechanisms involved in the generation of protective and pathogenic immune responses in human Chagas disease","volume":"104","author":"WO Dutra","year":"2009","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1128\/CVI.00142-08","article-title":"Novel protective antigens expressed by Trypanosoma cruzi amastigotes provide immunity to mice highly susceptible to Chagas&apos; disease","volume":"15","author":"E Silveira","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1371\/journal.ppat.0020077","article-title":"CD8+ T-Cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes","volume":"2","author":"D Martin","year":"2006","journal-title":"PLoS Pathog"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Theiler M, Smith HH (2000) The use of yellow fever virus modified by in vitro cultivation for human immunization. J. Exp. Med. 65, 787\u2013800 (1937). Rev Med Virol 10: 6\u201316; discussion 13\u201315.","DOI":"10.1002\/(SICI)1099-1654(200001\/02)10:1<3::AID-RMV261>3.0.CO;2-O"},{"key":"ref46","first-page":"895","article-title":"Persistence of neutralizing antibody 30\u201335 years after immunization with 17D yellow fever vaccine","volume":"59","author":"J Poland","year":"1981","journal-title":"Bull World Health Organ"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s11908-996-0005-9","article-title":"Current Assessment of Yellow Fever and Yellow Fever Vaccine","volume":"6","author":"A Lefeuvre","year":"2004","journal-title":"Curr Infect Dis Rep"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1084\/jem.20051720","article-title":"Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity","volume":"203","author":"T Querec","year":"2006","journal-title":"J Exp Med"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"4644","DOI":"10.1016\/j.vaccine.2010.04.071","article-title":"Immunogenicity and protective efficacy of a recombinant yellow fever vaccine against the murine malarial parasite Plasmodium yoelii","volume":"28","author":"C Stoyanov","year":"2010","journal-title":"Vaccine"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"5676","DOI":"10.1016\/j.vaccine.2010.06.052","article-title":"Evaluation of yellow fever virus 17D strain as a new vector for HIV-1 vaccine development","volume":"28","author":"D Franco","year":"2010","journal-title":"Vaccine"},{"key":"ref51","first-page":"151","article-title":"Human cytotoxic T lymphocyte responses to live attenuated 17D yellow fever vaccine: identification of HLA-B35-restricted CTL epitopes on nonstructural proteins NS1, NS2b, NS3, and the structural protein E. Virology","volume":"293","author":"M Co","year":"2002"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1006\/viro.2002.1432","article-title":"Yellow fever virus 17D envelope and NS3 proteins are major targets of the antiviral T cell response in mice","volume":"296","author":"RG van der Most","year":"2002","journal-title":"Virology"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.immuni.2008.02.020","article-title":"Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines","volume":"28","author":"J Miller","year":"2008","journal-title":"Immunity"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0065-3527(03)60009-6","article-title":"Pathogenesis and pathophysiology of yellow fever","volume":"60","author":"T Monath","year":"2003","journal-title":"Adv Virus Res"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"8183","DOI":"10.1016\/j.vaccine.2010.09.090","article-title":"CD8+ gamma-delta TCR+ and CD4+ T cells produce IFN-\u03b3 at 5\u20137 days after yellow fever vaccination in Indian rhesus macaques, before the induction of classical antigen-specific T cell responses","volume":"28","author":"PC Neves","year":"2010","journal-title":"Vaccine"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"e393","DOI":"10.1371\/journal.pone.0000393","article-title":"Modulation of CD4(+) T cell-dependent specific cytotoxic CD8(+) T cells differentiation and proliferation by the timing of increase in the pathogen load","volume":"2","author":"F Tzelepis","year":"2007","journal-title":"PLoS One"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1743-422X-8-127","article-title":"Biological and immunological characterization of recombinant Yellow Fever 17D viruses expressing a Trypanosoma cruzi Amastigote Surface Protein-2 CD8+ T cell epitope at two distinct regions of the genome","volume":"8","author":"RT Nogueira","year":"2011","journal-title":"Virol J"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1743-422X-4-115","article-title":"Construction and characterization of recombinant flaviviruses bearing insertions between E and NS1 genes","volume":"4","author":"M Bonaldo","year":"2007","journal-title":"Virol J"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1128\/JVI.02255-09","article-title":"Recombinant yellow fever vaccine virus 17D expressing simian immunodeficiency virus SIVmac239 gag induces SIV-specific CD8+ T-cell responses in rhesus macaques","volume":"84","author":"M Bonaldo","year":"2010","journal-title":"J Virol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1128\/IAI.71.5.2744-2757.2003","article-title":"Immunization with cDNA expressed by amastigotes of Trypanosoma cruzi elicits protective immune response against experimental infection","volume":"71","author":"S Boscardin","year":"2003","journal-title":"Infect Immun"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1006\/jmbi.2001.5258","article-title":"Surface expression of an immunodominant malaria protein B cell epitope by yellow fever virus","volume":"315","author":"M Bonaldo","year":"2002","journal-title":"J Mol Biol"},{"key":"ref62","first-page":"285","article-title":"Transcription of infectious yellow fever RNA from full-length cDNA templates produced by in vitro ligation","volume":"1","author":"C Rice","year":"1989","journal-title":"New Biol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/00034983.1969.11686622","article-title":"The behavior of slender and stout forms of Trypanosoma cruzi in the blood-stream of normal and immune mice","volume":"63","author":"Z Brener","year":"1969","journal-title":"Ann Trop Med Parasitol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"6645","DOI":"10.1016\/j.vaccine.2008.09.029","article-title":"Naturally acquired humoral and cellular immune responses to Plasmodium vivax merozoite surface protein 9 in Northwestern Amazon individuals","volume":"26","author":"JC Lima-Junior","year":"2008","journal-title":"Vaccine"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1586\/14760584.6.2.255","article-title":"Use of viral vectors for the development of vaccines","volume":"6","author":"M Liniger","year":"2007","journal-title":"Expert Rev Vaccines"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0166-6851(97)00088-1","article-title":"Molecular cloning of the gene encoding the 83 kDa amastigote surface protein and its identification as a member of the Trypanosoma cruzi sialidase superfamily","volume":"88","author":"HP Low","year":"1997","journal-title":"Molecular and biochemical parasitology"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.4049\/jimmunol.160.4.1817","article-title":"Amastigote surface proteins of Trypanosoma cruzi are targets for CD8+ CTL","volume":"160","author":"HP Low","year":"1998","journal-title":"Journal of immunology"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1172\/JCI3835","article-title":"Human infection with Trypanosoma cruzi induces parasite antigen-specific cytotoxic T lymphocyte responses","volume":"102","author":"B Wizel","year":"1998","journal-title":"The Journal of clinical investigation"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1590\/S0001-37652003000400005","article-title":"Importance of CD8 T cell-mediated immune response during intracellular parasitic infections and its implications for the development of effective vaccines","volume":"75","author":"MM Rodrigues","year":"2003","journal-title":"Anais da Academia Brasileira de Ciencias"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00251-010-0461-0","article-title":"The live-attenuated yellow fever vaccine 17D induces broad and potent T cell responses against several viral proteins in Indian rhesus macaques\u2013implications for recombinant vaccine design","volume":"62","author":"P Mudd","year":"2010","journal-title":"Immunogenetics"},{"key":"ref71","doi-asserted-by":"crossref","unstructured":"Reyes-Sandoval A, Rollier CS, Milicic A, Bauza K, Cottingham MG, <etal>et al<\/etal>.. (2012) Mixed Vector Immunization With Recombinant Adenovirus and MVA Can Improve Vaccine Efficacy While Decreasing Antivector Immunity. Mol Ther.","DOI":"10.1038\/mt.2012.25"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.parint.2007.07.005","article-title":"Trypanosoma cruzi infection from the view of CD8+ T cell immunity\u2013an infection model for developing T cell vaccine","volume":"57","author":"Y Miyahira","year":"2008","journal-title":"Parasitol Int"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nri2359","article-title":"The endoplasmic reticulum stress response in immunity and autoimmunity","volume":"8","author":"DJ Todd","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nri2545","article-title":"Immunogenic and tolerogenic cell death","volume":"9","author":"DR Green","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/35100512","article-title":"Cross-presentation in viral immunity and self-tolerance","volume":"1","author":"W Heath","year":"2001","journal-title":"Nat Rev Immunol"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.coi.2010.01.022","article-title":"Intracellular mechanisms of antigen cross presentation in dendritic cells","volume":"22","author":"S Amigorena","year":"2010","journal-title":"Curr Opin Immunol"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri2868","article-title":"Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns","volume":"10","author":"MF Bachmann","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"7919","DOI":"10.4049\/jimmunol.0803903","article-title":"The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response","volume":"183","author":"R Akondy","year":"2009","journal-title":"J Immunol"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1128\/JVI.80.10.4717-4728.2006","article-title":"Induction of multifunctional human immunodeficiency virus type 1 (HIV-1)-specific T cells capable of proliferation in healthy subjects by using a prime-boost regimen of DNA- and modified vaccinia virus Ankara-vectored vaccines expressing HIV-1 Gag coupled to CD8+ T-cell epitopes","volume":"80","author":"N Goonetilleke","year":"2006","journal-title":"J Virol"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nri2274","article-title":"T-cell quality in memory and protection: implications for vaccine design","volume":"8","author":"RA Seder","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1590\/S0074-02762012000200017","article-title":"Retention of a recombinant GFP protein expressed by the yellow fever 17D virus in the E\/NS1 intergenic region in the endoplasmic reticulum","volume":"107","author":"GF Trindade","year":"2012","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.micinf.2007.04.006","article-title":"Immunologically relevant strain polymorphism in the Amastigote Surface Protein 2 of Trypanosoma cruzi","volume":"9","author":"C Claser","year":"2007","journal-title":"Microbes Infect"}],"updated-by":[{"DOI":"10.1371\/annotation\/39b41d98-b117-41cf-b5de-b8486a67b1cd","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2013,11,8]],"date-time":"2013-11-08T00:00:00Z","timestamp":1383868800000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0059347","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T11:09:58Z","timestamp":1688123398000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0059347"}},"subtitle":[],"editor":[{"given":"Simona","family":"Stager","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,3,19]]},"references-count":82,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,3,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0059347","relation":{"correction":[{"id-type":"doi","id":"10.1371\/annotation\/39b41d98-b117-41cf-b5de-b8486a67b1cd","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,19]]}}}